Indeed, sotrastaurin (AEB071) is an oral immunosuppressant that inhibits classical and novel protein kinase C isotypes [49] which are important for T-cell signaling [50] and for the production of INF-γ and IL-17 [51] which are key elements in psoriasis. Here, IL17A is linked to psoriasis.